Kees De Joncheere
Kees de Joncheere was the Director of the Essential Medicines and HealthProducts Department at WHO Headquarters, Geneva until April 2016. Before this he worked for more than 10 years as Regional Advisor for Pharmaceuticals and Health Technologies in the WHO Regional Office for Europe, and more recently as the WHO Representative and Head of Country Office in Kiev, Ukraine. From the Netherlands, his international career began working with the Government of the Netherlands in a health services project in what was then North Yemen. For more than 10 years he served the Pan American Health Organization in Brazil, the Mercosur countries and Central America in the essential medicines area.
Kees de Joncheere holds a Master`s degree in pharmacy, a PharmD and a Master’s degree in business administration from the Universities of Groningen and Amsterdam in the Netherlands, and from National University, San Diego, USA / San José, Costa Rica.
His particular interest is in public policy in the area of medicines, especially pharmaceutical pricing and reimbursement, as well as approaches to strengthening medicines regulation and improving the prescribing and use of medicines. He co-edited the WHO publication Drugs and Money, 7th edition, and is author of several articles and book chapters on pharmaceutical issues.
Selected publications of interest:
Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference.
Vogler S, Zimmermann N, Ferrario A, Wirtz VJ, de Joncheere K, Pedersen HB, Dedet G, Paris V, Mantel-Teeuwisse AK, Babar ZU; Scientific Programme Committee of the 2015 PPRI Conference. J Pharm Policy Pract. 2016 Mar 15;9:9.
Tough decisions on essential medicines in 2015. Magrini N, Robertson J, Forte G, Cappello B, Moja LP, de Joncheere K, Kieny MP. Bull World Health Organ. 2015 Apr 1;93(4):283-4. doi: 10.2471/BLT.15.154385. Epub 2015 Mar 12. No abstract available.
Medicines availability for non-communicable diseases: the case for standardized monitoring. Robertson J, Macé C, Forte G, de Joncheere K, Beran D. Global Health. 2015 May 7;11:18. doi: 10.1186/s12992-015-0105-0.
Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries.
Leopold C, Mantel-Teeuwisse AK, Vogler S, Valkova S, de Joncheere K, Leufkens HG, Wagner AK, Ross-Degnan D, Laing R. Bull World Health Organ. 2014 Sep 1;92(9):630-640D.
On WHO’s essential medicines process and transparency. Magrini N, Robertson J, de Joncheere K, Bero L. BMJ. 2014 Sep 17;349:g5637.